Immunopathogenesis of viral hepatitis

Bailliere's Clinical Gastroenterology

Volumn 10, Issue 3, 1996, Pages 483-500

  Rehermann, Barbara ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; POLYCLONAL ANTIBODY;

CHRONIC HEPATITIS; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; HEPATITIS; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LIVER CIRRHOSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW;

EID: 0029808602     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(96)90054-8     Document Type: Article

References (92)

1. Akatsuka T, Donets M, Scaglione L et al (1993)B cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies. Hepatology 18: 503-510.
2. Alter MJ, Margolis HS, Krawczynski K et al (1992) The natural history of community-acquired hepatitis C in the United States. New England Journal of Medicine 327: 1899-1905.
3. Ando K, Guidotti LG, Cerny A et al (1994a) Access to antigen restricts cytotoxic T lymphocyte function in vivo. Journal of Immunology 153: 482-489.
4. Ando K, Guidotti LG, Wirth S et al (1994b) Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target-cells in vivo. Journal of Immunology 152: 3245-3253.
5. Arakawa K, Tsuda F, Takahashi K et al (1982) Maternofetal transmission of IgG-bound hepatitis B e antigen. Pediatric Research 16: 247-250.
6. Archer AC, Cohen BJ & Mortimer PP (1983) The value of screening blood donors for antibody to hepatitis B core antigen. Journal of Clinical Pathology 36: 924-928.
7. Ashton-Rickardt PG & Murray K (1989) Mutants of the hepatitis B surface antigen that define some antigenically essential residues in the immunodominant a region. Journal of Medical Virology 29: 196-203.
8. Badardin KA & Desmet VJ (1984) Interdigitating and dendritic reticulum cells in chronic active hepatitis. Histopathology 8: 657-667.
9. Barnaba V, Franco A, Alberti A (1989) Recognition of hepatitis B envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. Journal of Immunology 143: 2650-2655.
10. Beasley RP & Hwang L (1983) Postnatal infectivity of hepatitis B surface antigen-carrier mothers Journal of Infectious Diseases 147: 185-190.
11. Beasley RP, Hwang LY, Stevens CE et al (1993) Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 3: 135-141.
12. Bertoletti A, Ferrari C, Fiaccadori F, et al (1991) HLA class-I restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proceedings of the National Academy of Sciences of the USA 88: 10 445-10 449.
13. Blum HE, Stowring L, Figus A et al (1983) Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium and, vascular elements by in situ hybridization. Proceedings of the National Academy of Science of the USA 80: 6682-6685.
14. Brook MG, Karayiannis P & Thomas HC (1989) Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predicitive factors. Hepatology 10: 761-763.
15. Carmen WF, Zanetti AR, Karayiannis P et al (1990) Vaccine induced escape mutant of hepatitis B virus. Lancet 336: 325-329.
16. Celis E, Ou D & Otvos L (1988) Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. Journal of Immunology 140: 1808-1815.
17. Cerino A & Mondelli MU (1991) Identification of an immunodomonant B cell epitope on the hepatitis C virus non-structural region defined by human monoclonal antibodies. Journal of Immunology 147: 2692-2696.
18. Cerny A, McHutchison JG, Pasquinelli C et al (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. Journal of Clinical Investigations 95: 521-530.
19. Chang LJ, Dienstag J, Ganem D & Varmus H (1989) Detection of antibodies against hepatitis B polymerase antigen in hepatitis ZB virus-infected patients. Hepatology 10: 332-337.
20. Chisari FV, Ferrari C & Mondelli MU (1989) Hepatitis B virus structure and biology. Microbiological Pathology 6: 311-325.
21. Choo Q-L, Kuo G, Weiner AJ et al (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362.
22. Davis HL, Michel M-L & Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis surface antigen and high levels of circulating antibody. Human Molecular Genetics 2: 1847-1851.
23. Degos F, Lugassy C, Degott C et al (1988) Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: a prospective study of 90 patients. Gastroenterology 94: 151-156.
24. Dejean A, Lugassy C, Zafrani S et al (1984) Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. Journal of General Virology 65: 651-655.
25. Dienes HP, Hütteroth T, Hess G & Meuer SC (1987) Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology 7: 1317-1325.
26. Diepolder HM, Zachoval R, Hoffmann RM et al (1995) Possible mechanism involving T lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007
27. Doherty PC, Allan W & Eichelberger M (1992) Roles of ab and gd T cell subsets in viral immunity. Annual Review of Immunology 10: 123-151.
28. Eble BE, MacRae DR, Lingappa VR & Ganem D (1987) Multiple topogenic sequences determine the transmembrane orientation of hepatitis B surface antigen. Molecular and Cellular Biology 7: 3591-3601.
29. Eckhardt SG, Milich DR & McLachlan A (1991) Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus. Journal of Virology 65: 575-582.
30. Eggink HF, Houthoff HJ, Huitema S et al (1982) Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clinical and Experimental Immunology 50: 17-24.
31. Erickson AL, Houghton M, Choo Q-L et al. (1993) Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. Journal of Immunology 151: 4189-4199.
32. Feitelson MA, Millman I, Duncan GD & Blumberg BS (1988) Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections. Journal of Medical Virology 24: 121-126.
33. Ferrari C, Penna A, Bertoletti A et al (1990) Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. Journal of Immunology 145: 3442-3449.
34. Ferrari C, Bertoletti A, Penna A et al (1991) Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. Journal of Clinical Investigation 88: 214-222.
35. Franco A, Paroli M, Testa U et al (1992) Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. Journal of Experimental Medicine 175: 1195-1205.
36. Gilles PN, Fey G & Chisari FV (1992) Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. Journal of Virology 66: 3955-3960.
37. Guidotti LG, Ando K, Hobbs MV et al (1994a) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proceedings of the National Academy of Sciences of the USA 91: 3764-3768.
38. Guidotti LG, Guilhot S & Chisari FV (1994b) Interleukin 2 and Interferon alph/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways. Journal of Virology 68: 1265-1270.
39. Guidotti LG, Ishikawa T, Hobbs MV et al (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 35-36.
40. Guilhot S, Fowler P, Portillo G et al (1992) Hepatitis B virus (HBV) specific cytolytic T cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B cell lines. Journal of Virology 66: 2670-2678.
41. Hadler SC, Judson FN, O'Mailley PM et al (1991) Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. Journal of Infectious Diseases 4: 454-459.
42. Harrison TJ, Hopes EA, Oon CJ et al (1991) Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. Journal of Hepatology 13: S105-S107.
43. Hollinger FB (1990) Hepatitis B virus. In Fields BN, Knipe DM et al (eds) Virology, pp 2171-2236. New York: Raven Press.
44. Husby G, Blomhoff JP, Elgjo K & Williams SRC Jr (1982) Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease. Scandinavian Journal of Gastroenterology 17: 855-860.
45. Ishida C, Matsumoto K, Fukada K et al (1993) Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-postive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. Journal of Clinical Microbiology 31: 936-940.
46. Jin Y, Shih W-K & Berkower I (1988) Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are acessible to both endogenous and exogenous antigen. Journal of Experimental Medicine 168: 293-306.
47. Korba BE, Cote PJ, Wells FV et al (1989) Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. Journal of Virology 63: 1360-1370.
48. Koziel MJ, Dudley D, Wong JT et al (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. Journal of Immunology 149: 3339-3344.
49. Koziel JM, Dudley D, Afdhal N et al (1993) Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. Journal of Virology 67: 7522-7532.
50. Koziel MJ, Dudley D, Afdhal N et al (1995) HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. Journal of Clinical Investigation 96: 2311-1221.
51. Krawczynski K & Bradley D W (1989) Enterically transmitted non-A, non-B hepatitis: identification of virus associated antigen in experimentelly infected cynomolgus macaques. Journal of Infectious Diseases 159: 1042-1047.
52. Leary TP, Muerhoff AS, Simons JN et al (1996) Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. Journal of Medical Virology 48: 60-67.
53. Lee KSD, Lo KJ, Wu JC et al (1986) Prevention of maternal-infant hepatitis B virus transmission by immunization. The role of serum hepatitis B virus DNA. Hepatology 6: 369-373.
54. Lemon SM, Whetter LE, Chang KH & Brown EA (1994) Recent advances in understanding the molecular virology of hepatoviruses: contrasts and comparisons with hepatitis C virus. In Nishioka K, Suzuki H, Mishiro S & Oda T (eds) Viral Hepatitis and Liver Disease, pp 22-27. Berlin: Springer-Verlag.
55. McDonald JA, Harris S, Water JA & Thomas HC (1987) Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B viral antigen display. Journal of Hepatology 4: 337-342.
56. Michel M-L, Pontisso P, Sobczahk E et al (1984) Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proceedings of the National Academy of Sciences of the USA 81: 7708-7712.
57. + T-cells specific for the protein NS4 of hepatitis C virus in patient with chronic hepatitis. Journal of Experimental Medicine 178: 17-26.
58. Missale G, Redeker A, Person J et al (1993) HLA-A31 and Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. Journal of Experimental Medicine 177: 751-762.
59. Montano L, Aranguibel F, Boffill M et al (1983) An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology 3: 292-296.
60. Moretta L, Ciccone E, Mingari MC et al (1994) Human natural killer cells: origin, clonality, specificity, receptors. Advances in Immunology 55: 341-358.
61. Nassal M (1995) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. Journal of Virology 66: 4107-4116.
62. Nayersina R, Fowler P, Guilhot S et al (1993) HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Journal of Immunology 150: 4659-4671.
63. Nishihara T (1983) Intrahepatic distribution of T cell and T cell subsets in cases with type B chronic liver disease by peroxidase-labeled antibody method using monoclonal antibodies. Gastroenterologia Japonica 18: 320-329.
64. Penna A, Fowler P, Bertoletti A et al (1992) Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. Journal of Virology 66: 1193-1198.
65. Pol S (1994) Specific vaccine therapy in chronic hepatitis B infection. Lancet 344: 342.
66. Rehermann B, Ferrari C & Chisari FV (1995a) The cytotoxic T lymphocyte response persists long after recovery from acute viral hepatitis. Hepatology 22: 223A (abstract).
67. Rehermann B, Fowler P, Sidney J et al (1995b) The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. Journal of Experimental Medicine 181: 1047-1058.
68. Rehermann B, Pasquinelli C, Mosier SM & Chisari FV (1995c) HBV sequence variation in CTL epitopes is not common in patients with chronic hepatitis B virus infection. Journal of Clinical Investigation 96: 1527-1534.
69. Rehermann B, Lau D, Hoofnagle J & Chisari FV (1996) Cytotoxic T Lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. Journal of Clinical Investigation 97: 1-11.
70. Rosa D, Campagnoli S, Moretto C et al (1996) A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proceedings of the National Academy of Sciences of the USA 93: 1759-1763.
71. Shimizu YK, Hijikita M, Iwamoto A et al (1994) Neutralizing antibodies against hepatitis C virus and the emergene of neutralization escape mutant viruses. Journal of Virology 68: 1494-1500.
72. Simmonds P, Rose KA, Graham S et al (1993) Mapping of serotype-specific, immunodominatn epitopes in the NS4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infection with HCV type 1, 2 and 3. Journal of Clinical Microbiology 31: 1493-1503.
73. Simons JN, Leary TP, Dawson GJ et al (1995) Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1: 564-569.
74. Szmuness WA, Prince AM, Grady GF et al (1974) Hepatitis B infection: a point prevalence study in 15 U.S. hemodialysis center. Journal of the American Medical Association 227: 901-906.
75. Szmuness W, Stevens CE, Harley EJ et al (1980) Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 303: 833-841.
76. Tam AW, Smith MJW, Guerra ME et al (1991) Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120-131.
77. Tiollais P, Pourcel C & Dejean A (1985) The hepatitis B virus. Nature 317: 489-495.
78. Tsai SL, Chen MY, Lai MY et al (1992) Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Journal of Clinical Investigation 89: 87-96.
79. Ulmer JB, Donnelly JJ, Parker SE et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749.
80. Valenzuela P, Medina A, Rutter WJ et al (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347-350.
81. Vitetta ES, Fernandez-Botran R, Myers CD & Sanders VM (1989) Cellular interactions in the humoral immune response. Advance in Immunology 45: 1-105.
82. Vitiello A, Ishioka G, Grey HM et al (1995) Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of a primary cytotoxic T lymphocyte response in humans. Journal of Clinical Investigation 95: 341-349.
83. Wands JR, Walker JR, Davis TT et al (1974) Hepatitis B in an oncology unit. New England Journal of Medicine 291: 1371-1375.
84. Wang B, Boyer J, Srikantan V et al (1993a) DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biology 12: 799-805.
85. Wang B, Ugen KE, Srikantan V et al (1993b) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the USA 980: 4156-4160.
86. Waters JA, Kennedy M, Voet P et al (1992) Loss of the common 'a' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. Journal of Clinical Investigation 90: 2543-2547.
87. Weimer T, Weimer K, Tu ZX et al (1989) Immunogenicity of human hepatitis B virus P-gene derived proteins. Journal of Immunology 143: 3750-3759.
88. Weimer T, Schödel F, Jung M-C et al (1990) Antibodies to the RNase H domain of hepatatis B virus P protein are associated with ongoing viral replication. Journal of Virology 64: 5665-5668.
89. Weiner A, Erickson AL, Kansopon J et al (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences USA 92: 2755-2759.
90. Xiang ZQ, Spitalnick S, Tran M et al (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132-140.
91. Yoffe B, Burns DK, Bhatt HS & Combes B (1990) Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology 12: 187-192.
92. Yuki N, Hayashi N, Kasahara A et al (1990) Detection of antibodies against the polymerase gene product in hepatitis B virus infection. Hepatalogy 12: 193-198.